Literature DB >> 6825392

Cigarette smoking and drug metabolism.

K Vähäkangas, O Pelkonen, E Sotaniemi.   

Abstract

Cigarette smoking appeared to induce total body drug metabolism, as indicated by decreased antipyrine t 1/2 and increased antipyrine clearance. The in vitro parameters of liver drug metabolism used (benzo(a)pyrene hydroxylase and cytochrome P-450 levels), however, were not changed. This implicates induction of drug metabolism in some other organ(s). Serum thiocyanate levels were higher in smokers than in exsmokers and nonsmokers. There was a certain amount of overlap between these groups; whether this reflects unreliability of smoking anamnesis or unspecificity of thiocyanate assay in discriminating between smokers and nonsmokers is not known. There was no significant correlation between serum thiocyanate and the other parameters studied.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825392     DOI: 10.1038/clpt.1983.48

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  4 in total

1.  Effects of smoking on benzo(alpha)pyrene- and glutathione-metabolizing enzymes in human lung tissue.

Authors:  C Bluhm
Journal:  Klin Wochenschr       Date:  1991-11-15

2.  The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status.

Authors:  M Pasanen; K Vahakangas; E A Sotaniemi; O Pelkonen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

3.  Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.

Authors:  S I Shedlofsky; B C Israel; C J McClain; D B Hill; R A Blouin
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

4.  The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies.

Authors:  O Pelkonen; M Pasanen; H Kuha; B Gachalyi; M Kairaluoma; E A Sotaniemi; S S Park; F K Friedman; H V Gelboin
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.